JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Hao, S. Articles by Fink, D. J. Search for Related Content PubMed PubMed Citation Articles by Hao, S. Articles by Fink, D. J. Related Collections Pain Pharmacology

---

PAIN MEDICINE

Nifedipine Potentiates the Antinociceptive Effect of Endomorphin-1 Microinjected into the Periaqueductal Gray in Rats

Shuanglin Hao, MD PhD^*,, Keiko Mamiya, MD^*, Osamu Takahata, MD PhD^*, Hiroshi Iwasaki, MD PhD^*, Marina Mata, MD, and David J. Fink, MD

*Department of Anesthesiology & Critical Care Medicine, Asahikawa Medical College, Asahikawa, Japan; and Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania

Address correspondence and reprint requests to Shuanglin Hao, MD, PhD, Department of Neurology, University of Pittsburgh Medical Center, S-522, BST, Pittsburgh, PA 15213. Address e-mail to haoshuanglin{at}hotmail.com

Endomorphin-1 is a novel endogenous µ-opioid ligand. We investigated the antinociceptive interaction between endomorphin-1 and nifedipine, an L-type calcium channel blocker, microinjected into the midbrain ventrolateral periaqueductal gray (vPAG), using the spinally-organized tail-flick test and the supraspinally-organized tail-pressure test in rats. Sprague-Dawley rats were stereotaxically implanted with a guide cannula lowered into the vPAG. Microinjection of endomorphin-1 into the vPAG led to dose-related increases in antinociceptive responses in the tail-flick test and tail-pressure test. Pretreatment with the µ-opioid receptor-selective antagonist ß-funaltrexamine blocked the antinociceptive effect of endomorphin-1. Pretreatment with ß-funaltrexamine alone had no effect on the tail-flick latency and tail-pressure threshold. Microinjection of nifedipine alone into the vPAG did not produce an antinociceptive response in the tail-flick test and tail-pressure test. However, injection of nifedipine into the vPAG potentiated the antinociceptive effect of endomorphin-1, producing a significant leftward shift in the dose-response curve of endomorphin-1 in both the tail-flick and tail-pressure tests. This result shows that the potent antinociceptive effect of endomorphin-1 microinjected into the vPAG is mediated through the µ-opioid receptor and is potentiated by concomitant administration of nifedipine.

IMPLICATIONS: This study shows that the potent antinociceptive effect of endomorphin-1 microinjected into the ventrolateral periaqueductal gray is potentiated by concomitant administration of nifedipine. This suggests that calcium channel blockers may enhance the analgesia of opioids in patients with calcium channel blocker treatment.

This article has been cited by other articles:

				S. Chiba, T. Nishiyama, and Y. Yamada The Antinociceptive Effects and Pharmacological Properties of JM-1232(-): A Novel Isoindoline Derivative Anesth. Analg., March 1, 2009; 108(3): 1008 - 1014. [Abstract] [Full Text] [PDF]

Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999